Robots will not replace surgeons in the foreseeable future. Every surgical robot currently in clinical use requires a human surgeon to operate it, and the vast majority of these systems function as sophisticated tools rather than independent decision-makers. A systematic review of all surgical robots cleared by the FDA from 2015 to 2023 found that 86% operate at the lowest level of autonomy, meaning they assist a surgeon who remains in full control.
What Surgical Robots Actually Do Today
The term “robotic surgery” is misleading. In practice, a surgeon sits at a console a few feet from the operating table, looking through a magnified 3D display and moving hand controllers. The robot translates those hand movements into precise motions of tiny instruments inside the patient’s body. It filters out hand tremors and can scale movements down, so a one-inch motion of the surgeon’s hand becomes a quarter-inch motion at the instrument tip. But the robot does not decide where to cut, how much tissue to remove, or when to change course. The surgeon makes every decision in real time.
The FDA has cleared robotic-assisted systems for use in general surgery, cardiac, colorectal, gynecologic, head and neck, thoracic, and urologic procedures. Common operations include gallbladder removal, hysterectomy, and prostatectomy. In all of these, the robot is a tool controlled by a trained physician in an operating room.
How Far Away Is Autonomous Surgery
Researchers classify surgical robots on a five-level scale, from Level 1 (robot assistance, where the surgeon controls everything) to Level 5 (full autonomy, where the robot performs surgery without human input). Of all FDA-cleared surgical robots reviewed between 2015 and 2023, none reached beyond Level 3. Only about 6% achieved Level 3, which is called “conditional autonomy,” meaning the robot can execute a specific pre-planned task on its own while the surgeon supervises and can intervene at any moment.
The three most advanced Level 3 systems handle narrow, repetitive tasks: milling bone to precise shapes in orthopedic surgery, performing prostate biopsies, and extracting hair follicles. These are structured procedures with predictable anatomy and little variation between patients. No system has been cleared for Level 4 (high autonomy) or Level 5 (full autonomy) in any surgical specialty.
One research prototype, the Smart Tissue Autonomous Robot (STAR), has demonstrated the potential for more complex autonomous work. In a study published in Science Translational Medicine, STAR performed suturing on intestinal tissue in pigs with results that were superior to both expert human surgeons and standard robotic-assisted techniques in terms of suture consistency and leak resistance. That result is impressive, but it involved a single, well-defined task (reconnecting two ends of intestine) under controlled lab conditions, not the unpredictable environment of a full human operation.
Why Human Surgeons Are Still Essential
Surgery is rarely a straight line from first incision to final stitch. Surgeons regularly encounter unexpected bleeding, scar tissue from previous operations, anatomical variations that differ from imaging, and tumors that have grown into surrounding structures in ways that weren’t visible on a scan. Handling these situations requires judgment built from years of training, pattern recognition across thousands of cases, and the ability to weigh risks in real time. No current AI system can reliably do this.
There’s also a fundamental sensory gap. The lack of haptic feedback is considered the main limitation of current robotic surgical systems. Surgeons rely on touch to locate hidden structures beneath tissue surfaces, to distinguish abnormal tissue from healthy tissue based on differences in firmness, and to gauge how much force to apply when handling delicate organs. Current robots don’t transmit this tactile information back to the surgeon’s hands. Researchers are exploring multimodal feedback systems that combine visual cues with vibration or audio signals, but the human brain doesn’t interpret these substitutes as naturally as direct touch. For inexperienced surgeons especially, the absence of touch feedback leads to applying too much force, which can damage tissue.
Remote surgery introduces another constraint: latency. Studies show that a round-trip signal delay beyond roughly 100 milliseconds impairs a surgeon’s hand-eye coordination. Fine motor accuracy starts declining around 120 milliseconds, and delays past 150 to 200 milliseconds significantly impair surgical precision. Japan’s remote surgery guidelines now mandate latency of 100 milliseconds or less. A fully autonomous robot wouldn’t face this particular problem, but it underscores how sensitive surgical work is to even tiny imperfections in control systems.
How Robotic Tools Improve Patient Outcomes
While robots aren’t replacing surgeons, they are making surgery better in measurable ways. In colorectal surgery, robotic-assisted procedures are associated with shorter hospital stays and fewer conversions to open surgery compared to standard laparoscopic (keyhole) approaches, though they do take longer in the operating room. For hysterectomy, robotic surgery is associated with about 52 milliliters less blood loss, fewer blood transfusions, and shorter hospital stays. In one study of gallbladder removal, the robotic group had a complication rate of 3.8% compared to 20.4% for the laparoscopic group.
A meta-analysis of 51 studies comparing robotic and laparoscopic stomach surgery found that robotic procedures generally had lower rates of postoperative complications, including fewer infections, less fluid accumulation, and fewer cases of pneumonia. Across multiple procedure types, the pooled mortality rate was 0.4% for robotic procedures compared to 1.7% for laparoscopic ones. For prostate removal, robotic surgery was associated with shorter catheter time and shorter hospital stays, though overall complication rates were similar between the two approaches in randomized trials.
These improvements come from the robot’s precision, not its independence. The surgeon still drives every move.
The Cost of Surgical Robots
Adopting robotic surgery is expensive. A da Vinci surgical system costs between $1 million and $2.3 million to purchase, with annual maintenance contracts running $100,000 to $150,000. On top of that, the instruments used during each procedure are either disposable or have a limited number of uses before they must be replaced. These costs are passed along to hospitals and, ultimately, to patients and insurers. For many hospitals, especially smaller or rural ones, the investment is difficult to justify unless surgical volume is high enough to spread the cost across many procedures.
This economic reality also works against the idea of robots replacing surgeons. Even the most advanced robotic system still requires a trained surgeon to operate it, a surgical team to prepare the patient and manage anesthesia, and nurses to assist. The robot adds a layer of cost on top of existing staffing, rather than reducing it.
The Surgeon Shortage Problem
Projections from the Bureau of Health Workforce paint a picture that makes surgeon replacement seem unlikely for another reason: there aren’t enough surgeons as it is. By 2035, the U.S. is projected to meet only 69% of its demand for thoracic surgeons, 75% for plastic surgeons, 83% for urologists, 84% for vascular surgeons, and 89% for neurosurgeons. Orthopedic surgery is projected to meet 91% of demand. Only general surgery and colorectal surgery are expected to roughly match supply with demand.
These shortages mean the practical role of robotic and AI-assisted systems is more likely to extend what existing surgeons can do, not to eliminate their jobs. A surgeon using robotic tools can operate with greater precision, potentially take on more complex cases, and in the future may be able to supervise semi-autonomous steps that free up time for the parts of surgery that require the most judgment.
Who Is Liable When Something Goes Wrong
Legal trends reinforce the human-centered nature of robotic surgery. A review of litigation related to robotic urologic surgery found that almost all malpractice claims were based on surgical complications, not device failure. Robot malfunction was alleged in only two claims. Courts are treating robotic surgery the same way they treat any other surgical procedure: the surgeon, not the machine, is responsible for the outcome. This legal framework would need to be fundamentally reworked before any hospital or regulatory body would allow a robot to operate without a surgeon in control, and no such legal shift is underway.
For the foreseeable future, surgical robots will continue to evolve as increasingly capable tools that make surgeons more precise, reduce patient recovery times, and expand access to minimally invasive procedures. The surgeon’s role will change, becoming more supervisory for certain routine steps, but the core of surgery, making high-stakes decisions about a unique human body in real time, remains firmly human work.